Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes.

Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes.
复制标题

DOI:
10.1084/jem.173.4.923
复制
发表时间:
1991-04-01
影响因子:
15.3
通讯作者:
Grabstein, K H
Grabstein, K H
中科院分区:
医学1区
文献类型:
--
作者:
Alderson, M R;Tough, T W;Ziegler, S F;Grabstein, K H

文献摘要

被引文献

相似文献

外周血单核细胞可被刺激物如细菌脂多糖(LPS)诱导以分泌一系列细胞因子。我们研究了白细胞介素7(IL-7)对人外周血单个核细胞(PBMC)的作用,发现IL-7是一种较强的IL-6分泌诱导剂。用B 9杂交瘤生长因子法和酶联免疫吸附法测定IL-6蛋白水平,用北方杂交法测定IL-6 mRNA水平。详细检查显示,在PBMC中,单核细胞而不是淋巴细胞分泌IL-6以响应IL-7。与刺激T细胞生长和分化所需的低浓度IL-7(低至0.1ng/ml)相反,诱导单核细胞分泌IL-6需要相对高浓度的IL-7(至少10 ng/ml)。最佳浓度的IL-7(100 ng/ml)诱导单核细胞分泌比最佳浓度的IL-1 β(10 ng/ml)多10倍的IL-6,并且几乎与LPS一样多。然而,诱导可检测水平的IL- 6需要比IL-1 β显著更多的IL-7。单核细胞分泌IL-6的动力学与IL-7、IL-1 β或LPS的反应相同,早在培养开始后2 h,培养上清液中就可检测到IL-6蛋白。IL-4可明显抑制IL-7或LPS诱导IL-6 mRNA和IL-6分泌的能力。除了促进IL-6的产生外,IL-7还诱导单核细胞分泌免疫反应性IL-1 α、IL-1 β和肿瘤坏死因子α(TNF-α)。IL-7还诱导单核细胞/巨噬细胞对人黑色素瘤细胞靶标的杀肿瘤活性,该活性可能与IL-1 α、IL-1 β和TNF-α的分泌有关。最后,我们使用全血培养系统作为体内分析的桥梁,以证明IL-7在不存在培养基、胎牛血清和粘附塑料的情况下诱导细胞因子分泌。我们的数据表明,IL-7,除了调节淋巴细胞的生长和分化,对单核细胞谱系的细胞具有强大的影响。因此,IL-7可能是炎症和巨噬细胞对肿瘤的免疫应答中的重要介质。
Peripheral blood monocytes can be induced by stimuli such as bacterial lipopolysaccharide (LPS) to secrete an array of cytokines. We have studied the effects of interleukin 7 (IL-7) on human peripheral blood mononuclear cells (PBMC) and found that IL-7 is a relatively potent inducer of IL-6 secretion IL-6 protein levels were determined either by the B9 hybridoma growth factor assay or by enzyme-linked immunosorbent assay, and mRNA for IL-6 was analyzed by Northern hybridization. Detailed examination revealed that, among PBMC, monocytes, rather than lymphocytes, were secreting IL-6 in response to IL-7. In contrast to the low concentrations of IL-7 required to stimulate T cell growth and differentiation (as low as 0.1 ng/ml), relatively high concentrations of IL-7 were necessary to induce IL-6 secretion by monocytes (at least 10 ng/ml). An optimal concentration of IL-7 (100 ng/ml) induced monocytes to secrete 10-fold more IL-6 than an optimal concentration of IL-1 beta (10 ng/ml), and almost as much as LPS. However, significantly more IL-7 than IL-1 beta was required to induce detectable levels of IL- 6. The kinetics of IL-6 secretion by monocytes were identical in response to IL-7, IL-1 beta, or LPS, with IL-6 protein detectable in culture supernatants as early as 2 h after the initiation of culture. IL-4 was found to markedly inhibit the ability of IL-7 or LPS to induce IL-6 mRNA and IL-6 secretion. In addition to promoting IL-6 production, IL-7 induced the secretion of immunoreactive IL-1 alpha, IL-1 beta, and tumor necrosis factor alpha (TNF-alpha) by monocytes. IL-7 also induced monocyte/macrophage tumoricidal activity against a human melanoma cell target, an activity that may be related to the secretion of IL-1 alpha, IL-1 beta, and TNF-alpha. Finally, we used a whole blood culture system as a bridge to in vivo analysis to demonstrate that IL-7 induces cytokine secretion in the absence of culture medium, fetal calf serum, and adherence to plastic. Our data suggest that IL-7, in addition to regulating lymphocyte growth and differentiation, has potent effects on cells of the monocytic lineage. Thus, IL-7 may be an important mediator in inflammation and in the macrophage immune response to tumors.